Moderna’s non-vaccine mRNA therapeutic can generate $278 million in 2028 if approved: GlobalData EP News Bureau Feb 16, 2023 mRNA-3927 targets a rare genetic disorder, propionic acidemia, in which patients are unable to process certain parts of proteins…
